Navigation Links
Public Citizen, Demand Progress and RxRights.org Join Others Opposing U.S. Pharmacy Industry Group From Controlling “.Pharmacy” Domain Registration
Date:5/30/2013

White Plains, NY (PRWEB) May 30, 2013

Consumer watchdog and activist groups, Public Citizen, Demand Progress, and RxRights.org have joined a chorus of others opposing a bid by the National Association of Boards of Pharmacy (NABP) to control the registry of a proposed new Internet domain ending in “.Pharmacy” (dot pharmacy). NABP’s goal is to create a marketplace where only those websites ending in .Pharmacy are considered legitimate, but NABP’s standards would ban any online pharmacy outside the U.S. that sells to Americans from being registered, including those legally operating in Canada with licenses verified by PharmacyChecker.com. Millions of Americans rely on affordable medication purchased from such pharmacies.

Opponents of NABP’s bid believe its actions will advantage pharmaceutical companies and U.S. pharmacies by protecting their profits and sales to the disadvantage of American consumers whose access to medicines will be curtailed.

The NABP application for .Pharmacy has passed the Internet Corporation of Assigned Names and Numbers’ (ICANN) initial evaluation criteria but its final approval remains uncertain.

NABP proposes to act as an impartial organization in making the rules for Internet pharmacies on a worldwide basis, but its application is funded by Merck, Eli Lilly and other drug companies. Its executive committee includes executives and employees of chain pharmacies in the U.S., such as CVS, Walgreens, and Walmart. Those industries have strenuously lobbied against personal drug importation for over the last decade and pressured the White House to dissuade consumers from buying medication outside the United States.

Here’s what activists have written about NABP’s application:

Public Citizen’s Peter Maybarduk, JD, Program Director of Global Access to Medicines:
“NABP has proposed an unfair standard that would bar online pharmacies that serve US consumers but are located outside of the United States from using the domain (see NABP’s application at Section 18(a) IV*). This would exclude many licensed pharmacies which offer American consumers low-cost medicines of quality.”

Demand Progress’s David Moon, JD, Program Director

“From our direct experience with NABP and its allies in Internet policy disputes, there is ample cause to believe the applicant seeks to control .pharmacy to the detriment of free speech & access to safe and affordable medication for consumers. Members of the pharmaceutical industry who support NABP's application have consistently conflated online retailers selling counterfeit drug sales with those selling legitimate products. Their true goal is to control markets and gain the ability to disconnect competitors from the Net.”

RxRights.org‘s Lee Graczyk, Executive Director,

“Empirical study shows that the biggest barrier to medication adherence is cost. Forty-eight million Americans did not fill a prescription due to cost in 2010, according to the Commonwealth Fund. Therefore, consumers will most benefit from a trusted, open, and competitive .PHARMACY space. It should not be used to protect the market share of U.S. pharmaceutical entities nor settle cross-border legal ambiguities to consumers’ detriment.”

PharmacyChecker.com helps Americans find the best drug prices from verified online pharmacies. PharmacyChecker.com's pharmacy ratings and drug price comparisons are free to consumers. PharmacyChecker.com, based in New York, is privately held with no ownership in or from companies that sell or distribute pharmacy products.

Read the full story at http://www.prweb.com/releases/oppose/NABP-ICANN/prweb10780126.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Spends Too Little on Public Health Initiatives: Report
2. Physicians call for improvements to countrys public health system to protect US residents
3. Publication Bias Casts Doubt on Value of Antidepressants for Autism
4. Comprehensive report documents impact of urologic diseases on American public
5. Surgeon General receives 2012 Distinguished Public Service Award from internal medicine physicians
6. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
7. As New Premature Ejaculation Drugs Get Closer To The Public Market, LastLonger2Night.com Announces A Drug-Free Solution
8. Higher levels of public reimbursement positively influence national birth rates and reduce unmet needs in subfertile populations
9. Oxford University Press launches Evolution, Medicine, and Public Health
10. $53 million grant will help health researchers develop new therapies -- with the publics help
11. Tobacco use more prevalent among African-American adolescents living in public housing communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, LLC ... steel (PLS) columns combine the strength of traditional stainless steel with the chemical ... samples while operating at ultra-high pressures of 20,000 psi. The higher operating pressures ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016  Rich Pharmaceuticals, ... today announced a 1-for-100 reverse split of its issued ... opening of trading on Thursday, February 11, 2016. The ... under new CUSIP number 76303T308 and temporary ticker symbol ... commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology: